Recombinant human insulin (Eastgate Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human insulin (Eastgate Biotech)
Drug Alias Name重组人胰岛素-Eastgate BiotechEGP-1214
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsPrediabetic StateDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesEastgate Biotech
China Registration ClassN/A

Develop Information

Active CompaniesEastgate Biotech
Inactive CompaniesN/A
Active IndicationsPrediabetic StateDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A